This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Ensign Group (ENSG) Stock a Solid Choice Right Now?
by Zacks Equity Research
Ensign Group (ENSG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights: Ensign, Gaia, MEI Pharma, Turning Point Brands and A10 Networks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ensign, Gaia, MEI Pharma, Turning Point Brands and A10 Networks
5 Top Stocks That Have Skyrocketed in the Past 7 Days
by Nalak Das
Despite the coronavirus-induced market downturn, a handful of stocks have soared in the last seven trading days defying the overall market trend.
Looking for a Growth Stock? 3 Reasons Why Ensign Group (ENSG) is a Solid Choice
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: Calix, CBIZ, The Ensign Group, Regeneron Pharmaceuticals and Turning Point Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Calix, CBIZ, The Ensign Group, Regeneron Pharmaceuticals and Turning Point Brands
Market is Wavering! Buy 5 Best Low-Volatility Stocks Now
by Tirthankar Chakraborty
Low-volatility stocks tend to hold up better in tough times. More interestingly, these stocks have done better over longer periods of time, even before the coronavirus-induced market crash.
Brookdale Scraps Earnings View Due to COVID-19 Uncertainty
by Zacks Equity Research
Brookdale (BKD) pulls down 2020 earnings guidance, takes steps to preserve liquidity and incurs additional cost for prevention measures.
Bet on These High Earnings Yield Stocks Amid Coronavirus Scare
by Zacks Equity Research
Check out these five stocks with high earnings yield to power your portfolio.
Looking for a Growth Stock? Why It is Time to Focus on Ensign Group (ENSG)
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Ensign Group (ENSG).
Is The Ensign Group (ENSG) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (ENSG) Outperforming Other Medical Stocks This Year?
Why Is Ensign Group (ENSG) Down 13.8% Since Last Earnings Report?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group Expands Colorado Presence With Twin Buyouts
by Zacks Equity Research
Ensign Group (ENSG) continues with its buyout binge by acquiring nursing facilities in Colorado.
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
New Covid-19 Cases Increase, 5 Defensive Stocks to Buy
by Zacks Equity Research
Here are five defensive stocks that can shield your portfolio as Covid-19 continues to spread, instilling volatility in the stock market.
New Strong Buy Stocks for February 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Ensign Group (ENSG) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 9.09% and 3.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Hold Strategy is Apt for Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) is well-positioned to reap benefits for investors on the back of its rising top line, capital strength and solid performances at both Acute Care and Behavioral Health segments.
Ensign Acquires Healthcare Center, Buyout Spree Continues
by Sapna Bagaria
The acquisition of Healthcare Center adds to Ensign Group's (ENSG) portfolio of skilled nursing and independent living services.
Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives
by Zacks Equity Research
Ensign Group (ENSG) clears a quarterly dividend hike to share more profits with investors.
Ensign Group (ENSG) on Buyout Binge to Boost Capabilities
by Zacks Equity Research
Ensign Group's (ENSG) acquisition spree in Texas and Arizona will enhance its portfolio and better serve the local communities.
Ensign Group's (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings suffer escalating expenses.
Ensign Group (ENSG) Q3 Earnings Lag Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of -1.79% and 0.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nursing Industry Outlook Buoyant on Increasing Life Expectancy
by Sapna Bagaria
Aging baby boomer population, need for low-cost care facilities and consolidation should aid the growth of the nursing industry.